eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Clinical research

Standardised tomato extract as an alternative to acetylsalicylic acid in patients with primary hypertension and high cardiovascular risk – a randomised, controlled trial

Beata Krasinska, Angelika Osińska, Maciej Osinski, Aleksandra Krasinska, Piotr Rzymski, Andrzej Tykarski, Zbigniew Krasiński

Arch Med Sci 2018; 14, 4: 773–780
Online publish date: 2017/09/05
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Cardiovascular (CV) diseases remain a leading global cause of death. It has been proven that the use of acetylsalicylic acid (ASA) in secondary prevention reduces the CV risk, while the benefits of ASA in primary prevention have recently been debated. The aim of the study was to compare the antiplatelet effect of standardised tomato extract (STE) and ASA in hypertensive patients with high CV risk.

Material and methods
The study involved high-risk patients with arterial hypertension (AH) randomly assigned to one of two groups: group 1 included 33 patients receiving ASA and group 2 included 32 patients receiving STE. The platelet aggregation was determined using the VerifyNow analyser.

After 4 weeks of ASA treatment in group 1, a statistically significant reduction in aspirin reaction units (ARU) was observed (p < 0.001). However, the obese subgroup using ASA (n = 18) did not reveal a significant decrease in ARU (p > 0.05). After 4 weeks of STE treatment in the obese subgroup (n = 14), significant declines in ARU by 8.6% (95% CI: –19.5 to –1.7%; p < 0.05) and in P2Y12 reaction units (PRU) by 7.5% (95% CI: –17.6 to 1.8%; p < 0.05) were observed.

The antiplatelet effect of STE in hypertensive patients may be weight dependent. The group with AH and obesity might have potentially benefitted from STE treatment.


anti-aggregation, arterial hypertension, high cardiovascular risk, obesity, diet supplement, standardised tomato extract

Sosnowska B, Penson P, Banach M. The role of nutraceuticals in the prevention of cardiovascular disease. Cardiovasc Diagn Ther 2017; 7 (Suppl 1): S21-31.
Cicero A, Colletti A, Bajraktari G, et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci 2017; 13: 965-1005.
Antithrombotic Trialists’ (ATT) Collaboration, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-60.
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-357.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-81.
Komosa A, Rzymski P, Perek B, et al. Platelets redox balance assessment: current evidence and methodological considerations. Vascular Pharmacol 2017; 93-95: 6-13.
O’Kennedy N, Raederstorff D, Duttaroy AK. “Fruitflow(®): the first European Food Safety Authority-approved natural cardio-protective functional ingredient. Eur J Nutr 2017; 56: 461-82.
Fuentes E, Forero-Doria O, Carrasco G, et al. Effect of tomato industrial processing on phenolic profile and antiplatelet activity. Molecules 2013; 18: 11526-36.
European Food Safety Authority (EFSA), Bresson JL, Flynn A, Heinonen M, et al. Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation. EFSA J 2009; 7:
Wożakowska-Kapłon B, Filipiak KJ, Mamcarz A, Nar­kiewicz K, Tykarski A, Widecka K. Miejsce wystandaryzowanego ekstraktu z pomidorów w prewencji pierwotnej schorzeń układu sercowo-naczyniowego. Czy i kiedy stanowi alternatywę dla kwasu acetylosalicylowego? Stanowisko grupy ekspertów. Folia Cardiol 2015; 10: 100-5.
Navarrete S, Alarcón M, Palomo I. Aqueous extract of tomato (Solanum lycopersicum L.) and ferulic acid reduce the expression of TNF-alpha and IL-1beta in LPS-activated macrophages. Molecules 2015; 20: 15319-29.
Biswas D, Uddin MM, Dizdarevic LL, et al. Inhibition of angiotensin-converting enzyme by aqueous extract of tomato. Eur J Nutr 2014; 53: 1699-706.
O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time- course cannulation study in healthy humans. Am J Clin Nutr 2006; 84: 570-9.
Faridi KF, Lupton JR, Martin SS, et al. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk. Arch Med Sci 2017; 13; 732-7.
Ghomari-Boukhatem H, Bouchouicha A, Mekki K, Chenni K, Belhadj M, Bouchenak M. Blood pressure, dyslipidemia and inflammatory factors are related to body mass index in scholar adolescents. Arch Med Sci 2017; 13: 46-52.
Ciccone MM, Cortese F, Gesualdo M, et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm 2013; 2013: 782137.
Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 2000; 72: 912-21.
Plaza L, Sánchez-Moreno C, Ancos BD, Cano MP. Carotenoid content and antioxidant capacity of Mediterranean vegetable soup (gazpacho) treated by high-pressure/temperature during refrigerated storage. Eur Food Res Technol 2006; 223; 210-5.
Cassar K, Bachoo P, Brittenden J. The role of platelets in peripheral vascular disease. Eur J Vasc Endovasc Surg 2003; 25: 6-15.
Cronenwett J, Johnston K. Rutherford’s Vascular Surgery. 8th ed. Vol. 2. Elsevier Expert Consult USA, 2014.
Tektonidis TG, Åkesson A, Gigante B, Wolk A, Larsson SC. Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. Eur J Heart Fail 2016; 18: 253-9.
Tektonidis TG, Åkesson A, Gigante B, Wolk A, Larsson SC. A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: a population-based cohort study. Atherosclerosis 2015; 243: 93-8.
Rees K, Hartley L, Flowers N, et al. Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 8: CD009825.
Burton-Freeman BM, Sesso HD. Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv Nutr 2014; 5: 457-85.
Jacques PF, Lyass A, Massaro JM, Vasan RS, Agostino RBD. Relationship of lycopene intake and consumption of tomato products to incident CVD. Br J Nutr 2013; 110: 545-51.
Ghavipour M, Saedisomeolia A, Djalali M, et al. Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br J Nutr 2013; 109: 2031-5.
Canene-Adams K, Campbell JK, Zaripheh S, Jeffery EH, Erdman JW. The tomato as a functional food. J Nutr 2005; 135: 1226-30.
Dutta-Roy AK, Crosbie L, Gordon MJ. Effects of tomato extract on human platelet aggregation in vitro. Platelets 2001; 12: 218-27.
O’Kennedy N, Crosbie L, Whelan S, et al. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr 2006; 84: 561-9.
Lazarus SA, Bowen K, Garg ML. Tomato juice and platelet aggregation in type 2 diabetes. JAMA 2004; 292: 805-6.
Rodríguez-Azúa R, Treuer A, Moore-Carrasco R, et al. Effect of tomato industrial processing (different hybrids, paste, and pomace) on inhibition of platelet function in vitro, ex vivo, and in vivo. J Med Food 2014; 17: 505-11.
Fuentes EJ, Astudillo LA, Gutiérrez MI, et al. Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity. Blood Coagul Fibrinolysis 2012; 23: 109-17.
Fuentes E, Palomo I. Relationship between platelet PPARs, cAMP levels, and P-selectin expression: antiplatelet activity of natural products. Evid Based Complement Alternat Med 2013; 2013: 861786.
Bordeaux BC, Qayyum R, Yanek LR, et al. Effect of obesity on platelet reactivity and response to low-dose aspirin. Prev Cardiol 2010; 13: 56-62.
Peace A, McCall M, Tedesco T, et al. The role of weight and enteric coating on aspirin response in cardiovascular patients. J Thromb Haemost 2010; 8: 2323-5.
Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010; 49: 71-87.
Bonello-Palot N, Armero S, Paganelli F, et al. Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention. Am J Cardiol 2009; 104: 1511-5.
Mayer K, Orban M, Bernlochner I, et al. Predictors of antiplatelet response to prasugrel during maintenance treatment. Platelets 2015; 26: 53-8.
Rocca B, Petrucci G. Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms. Thrombosis 2012; 2012; 376721.
Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48; 426-9.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe